Trademark: 79012124
Word
EFETRAN
Status Date
Sunday, June 19, 2011
Registration Number
3181116
Registration Date
Tuesday, December 5, 2006
Filing Date
Thursday, June 23, 2005
Published for Opposition
Tuesday, September 19, 2006
Cancellation Date
Sunday, June 19, 2011
5 Pharmaceutical preparations for the prevention and treatment of disorders of the central nervous system, the immune system, the cardiovascular system, the respiratory system, the musculo-skeletal system, for the treatment of inflammatory disorders, treatment of diabetes and metabolic diseases, for use in dermatology, for the treatment of cancer, and for the treatment of eye disorders or diseases; anti-infective, antiviral, and antibiotic preparations, antibacterial pharmaceutical preparations, antifungal pharmaceutical preparations
Jan 6, 2012
Death Of International Registration
Jun 27, 2009
Teas Change Of Correspondence Received
Jun 27, 2009
Teas Change Of Correspondence Received
Mar 28, 2008
Final Decision Transaction Processed By Ib
Jul 11, 2007
Final Disposition Notice Sent To Ib
Jul 11, 2007
Final Disposition Processed
Jul 6, 2007
Final Disposition Notice Created, To Be Sent To Ib
Dec 5, 2006
Registered-Principal Register
Sep 19, 2006
Published For Opposition
Aug 30, 2006
Notice Of Publication
Jul 22, 2006
Law Office Publication Review Completed
Jul 22, 2006
Assigned To Lie
Jul 14, 2006
Assigned To Lie
Jul 11, 2006
Approved For Pub - Principal Register
Jul 11, 2006
Examiner's Amendment Entered
Jul 11, 2006
Examiners Amendment E-Mailed
Jul 11, 2006
Examiners Amendment -Written
Mar 8, 2006
Attorney Revoked And/Or Appointed
Mar 8, 2006
Teas Revoke/Appoint Attorney Received
Feb 3, 2006
Refusal Processed By Ib
Jan 19, 2006
Non-Final Action Mailed - Refusal Sent To Ib
Jan 17, 2006
Non-Final Action (Ib Refusal) Prepared For Review
Jan 16, 2006
Non-Final Action Written
Jan 13, 2006
Assigned To Examiner
Aug 5, 2005
New Application Entered In Tram
Aug 4, 2005
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
